Nielsen M L, Justesen T
Scand J Gastroenterol. 1977;12(8):1003-8. doi: 10.3109/00365527709181365.
Excretion of metronidazole (MNZ) in the normal and in the diseased biliary tract was investigated in 58 patients after oral or intravenous administration of MNZ. After oral administration MNZ appeared rapidly in hepatic bile, and throughout the period of absorption and elimination almost identical concentrations of MNZ were found in serum and hepatic bile. After intravenous administration no significant differences were found between concentrations of MNZ in common duct bile and serum in the non-obstructed common duct; in common duct obstruction, concentrations of MNZ in common duct bile were 56--99 per cent of corresponding concentrations in serum. MNZ was concentrated in normal gallbladders. In patients with gallbladder stones and preserved function of the gallbladder and in patients with no function of the gallbladder but a patent cystic duct, no significant differences were found between concentrations of MNZ in gallbladder bile, common duct bile, and serum. In most gallbladders with the cystic duct blocked by a stone, no MNZ was found in gallbladder bile.
对58例患者口服或静脉给予甲硝唑(MNZ)后,研究了甲硝唑在正常和病变胆道中的排泄情况。口服MNZ后,其迅速出现在肝胆汁中,在整个吸收和消除期间,血清和肝胆汁中的MNZ浓度几乎相同。静脉给药后,在无梗阻胆总管中,胆总管胆汁和血清中MNZ浓度无显著差异;在胆总管梗阻时,胆总管胆汁中MNZ浓度为血清中相应浓度的56% - 99%。MNZ在正常胆囊中浓缩。在有胆结石且胆囊功能保留的患者以及胆囊无功能但胆囊管通畅的患者中,胆囊胆汁、胆总管胆汁和血清中的MNZ浓度无显著差异。在大多数胆囊管被结石阻塞的胆囊中,胆囊胆汁中未发现MNZ。